Phase 3 Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You live in the Capital Region of Denmark
- You are over 18 years old
- You have been diagnosed with atrial fibrillation (AF) that comes and goes or is ongoing (not permanent)
- You have had or are scheduled for a cardioversion procedure (a procedure to reset your heart rhythm) that was successful
- If you are a woman who could become pregnant, you are using an accepted form of contraception throughout the study and for 30 days after it ends (such as the pill, implant, injection, patch, vaginal ring, or an IUD); or you are past menopause or have had a procedure making pregnancy impossible
- You are willing and able to give written consent and follow the study requirements
- You are receiving the appropriate treatments for your atrial fibrillation and any related conditions, as judged by the study doctor
Who may not be able to join:
- You are already taking colchicine (the study drug) for another condition, such as gout
- You have a known allergy or bad reaction to colchicine
- Your blood pressure is very high and not controlled (confirm with trial site)
- You have had cancer of any type, except for certain successfully treated skin cancers, localised prostate cancer, or localised cervical changes (confirm with trial site)
- You have serious liver disease, such as cirrhosis or chronic active hepatitis
- You are on kidney dialysis (haemodialysis)
- Your kidneys are not working well enough, based on a blood test measuring kidney function (confirm with trial site)
- You are taking certain medications that could interfere with how colchicine works in your body (confirm with trial site for the specific list)
- You have permanent atrial fibrillation (where the heart is always out of rhythm)
- You are pregnant, breastfeeding, or planning to become pregnant during the study or within 6 months of finishing it
- You have had significant problems with drug or alcohol use in the past year
- You are currently taking or planning to take long-term steroid tablets or injections during the study (steroid creams or inhalers are allowed)
- You are planning to have an ablation procedure (a procedure using heat or cold to correct heart rhythm) as a treatment for AF
- You have had heart surgery or an ablation procedure in the last three months
- You have a chronic bowel condition such as Crohn's disease or ulcerative colitis, or you have ongoing long-term diarrhoea
- You have taken part in another clinical trial or used another experimental treatment within the last 30 days
- You have another medical or surgical condition that the study doctor feels could put you at risk or prevent you from completing the study
- Your heart is still in an abnormal rhythm (AF) at the time you would be enrolled in the study, confirmed by a heart tracing (ECG)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Adam Femerling Langhoff, M.D., Herlev and Gentofte Hospital
Phone: +4522552317
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Between-group difference in change in time to first AF admission measured in days
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.